Format

Send to

Choose Destination
Curr Drug Deliv. 2019;16(5):430-443. doi: 10.2174/1567201816666190123120915.

Cell-penetrating Peptides: Efficient Vectors for Vaccine Delivery.

Author information

1
School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia.
2
Institute of Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia.
3
School of Pharmacy, The University of Queensland, Woolloongabba, QLD 4102, Australia.

Abstract

Subunit vaccines are composed of pathogen fragments that, on their own, are generally poorly immunogenic. Therefore, the incorporation of an immunostimulating agent, e.g. adjuvant, into vaccine formulation is required. However, there are only a limited number of licenced adjuvants and their immunostimulating ability is often limited, while their toxicity can be substantial. To overcome these problems, a variety of vaccine delivery systems have been proposed. Most of them are designed to improve the stability of antigen in vivo and its delivery into immune cells. Cell-penetrating peptides (CPPs) are especially attractive component of antigen delivery systems as they have been widely used to enhance drug transport into the cells. Fusing or co-delivery of antigen with CPPs can enhance antigen uptake, processing and presentation by antigen presenting cells (APCs), which are the fundamental steps in initiating an immune response. This review describes the different mechanisms of CPP intercellular uptake and various CPP-based vaccine delivery strategies.

KEYWORDS:

Cell-penetrating peptide; adjuvant; antigen presenting cells; antigen uptake; humoral and cellular immunity; vaccine delivery.

PMID:
30760185
PMCID:
PMC6637094
DOI:
10.2174/1567201816666190123120915
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Bentham Science Publishers Ltd. Icon for PubMed Central
Loading ...
Support Center